André Vis, Evelien van Altena, Bernard Jansen-Stensland, Jose Koppes, Daniela Oprea-Lager. "The DUET-1 trial: Feasibility and toxicity outcomes and early oncological outcomes of 177 lutetium-PSMA radioligand therapy (RLT) alternated with 233 radium-dichloride in patients with metachronous oligorecurrent osseus hormone sensitive prostate cancer (mHSPC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e17083